HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ergoline-derived inverse agonists of the human h3 receptor for the treatment of narcolepsy.

Abstract
Ergoline derivative (6aR,9R)-4-(2-(dimethylamino)ethyl)-N-phenyl-9-(pyrrolidine-1-carbonyl)-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-7(4H)-carboxamide (1), a CXCR3 antagonist, also inhibits human histamine H3 receptors (H3R) and represents a structurally novel H3R inverse agonist chemotype. It displays favorable pharmacokinetic and in vitro safety profiles, and served as a lead compound in a program to explore ergoline derivatives as potential drug candidates for the treatment of narcolepsy. A key objective of this work was to enhance the safety and efficacy profiles of 1, while minimizing its duration of action to mitigate the episodes of insomnia documented with previously reported clinical candidates during the night following administration. Modifications to the ergoline core at positions 1, 6 and 8 were systematically investigated, and derivative 23 (1-((4aR,8R,9aR)-8-(hydroxymethyl)-1-(2-((R)-2-methylpyrrolidin-1-yl)ethyl)-4,4a,7,8,9,9a-hexahydroindolo[1,14-fg]quinolin-6(1H)-yl)ethanone) was identified as a promising lead compound. Derivative 23 has a desirable pharmacokinetic profile and demonstrated efficacy by enhancing brain concentrations of tele-methylhistamine, a major histamine metabolite. This validates the potential of the ergoline scaffold to serve as a template for the development of H3R inverse agonists.
AuthorsYves P Auberson, Thomas Troxler, Xuechun Zhang, Charles R Yang, Markus Fendt, Dominik Feuerbach, Yu-Chih Liu, Bharat Lagu, Andreas Lerchner, Mark Perrone, Lijun Lei, Chao Zhang, Chunxiu Wang, Tie-Lin Wang, Mark G Bock
JournalChemMedChem (ChemMedChem) Vol. 9 Issue 8 Pg. 1683-96 (Aug 2014) ISSN: 1860-7187 [Electronic] Germany
PMID24850792 (Publication Type: Journal Article)
Copyright© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Chemical References
  • 1-(8-(hydroxymethyl)-1-(2-(2-methylpyrrolidin-1-yl)ethyl)-4,4a,7,8,9,9a-hexahydroindolo(1,14-fg)quinolin-6(1H)-yl)ethanone
  • Ergolines
  • Histamine Agonists
  • Receptors, Histamine H3
Topics
  • Animals
  • Caco-2 Cells
  • Cell Line
  • Dogs
  • Drug Inverse Agonism
  • Ergolines (chemistry, pharmacokinetics, therapeutic use)
  • Half-Life
  • Histamine Agonists (chemistry, pharmacokinetics, therapeutic use)
  • Humans
  • Madin Darby Canine Kidney Cells
  • Male
  • Mice
  • Microsomes, Liver (metabolism)
  • Narcolepsy (drug therapy)
  • Protein Binding
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Histamine H3 (chemistry, metabolism)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: